Lotus Eye Hospital And Institute Ltd (LOTUSEYE) AI Stock Analysis

• Market Cap: ₹2.25B
• Dividend Yield: N/A
• Average Volume (3M): 2.23K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.92
• Revenue Growth: 3.28%
• EPS Growth: -52.11%
• Country: IN
• Employees: 336
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Care Facilities
• EPS (TTM): -0.13
• Shares Outstanding: 20,796,330
• 10 Day Avg. Volume: 4,541
• 30 Day Avg. Volume: 2,230
• PEG Ratio: -2.60
• Price to Book (P/B): 2.43
• Price to Sales (P/S): 2.94
• P/FCF Ratio: -68.62
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 64 Neutral
• Price Target: ₹116.00 ▼(-1.78% Downside)
• Action: Reiterated Date: 12/13/25
• Date: Action: Reiterated 12/13/25

Lotus Eye Hospital And Institute Ltd's stock score is primarily driven by strong technical momentum and a solid financial foundation. However, the high P/E ratio suggests overvaluation, and declining profit margins pose a risk to future profitability. The absence of earnings call insights and corporate events limits additional context.

Positive Factors

Revenue Growth

Sustained top-line growth over multiple years indicates expanding patient volumes and successful service delivery scaling. This durable demand trajectory supports capacity utilization, amortizes fixed costs, and provides a platform to invest in clinical capabilities and geographic expansion over the medium term.

Negative Factors

Margin Compression

Sharp and sustained margin erosion signals rising cost pressures or pricing limits in core services. If structural, declining profitability can undermine return on invested capital, restrict reinvestment capacity, and require either higher volumes, pricing power, or cost restructuring to restore long-term earnings quality.

Lotus Eye Hospital And Institute Ltd Business Overview & Revenue Model

Company Description

Lotus Eye Hospital and Institute Limited, an eye hospital, provides eye care services in India. It offers services in the areas of refractive surgery, retina and uvea, cornea, glaucoma, paediatric and squint, computer vision syndrome, orbit and oc...

Read more

Lotus Eye Hospital and Institute Limited, an eye hospital, provides eye care services in India. It offers services in the areas of refractive surgery, retina and uvea, cornea, glaucoma, paediatric and squint, computer vision syndrome, orbit and oc...

How the Company Makes Money

Lotus Eye Hospital and Institute Ltd primarily generates revenue by delivering paid eye-care services to patients through its facilities. Key revenue streams typically include (1) outpatient services such as consultations, diagnostic tests, refrac...

Read more

Lotus Eye Hospital and Institute Ltd primarily generates revenue by delivering paid eye-care services to patients through its facilities. Key revenue streams typically include (1) outpatient services such as consultations, diagnostic tests, refrac...

Lotus Eye Hospital And Institute Ltd Financial Statement Overview

Breakdown	TTM	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Income Statement
Total Revenue	503.15M	495.63M	482.10M	470.44M	389.10M	323.59M
Gross Profit	219.82M	100.41M	135.66M	121.38M	192.53M	85.70M
EBITDA	40.71M	47.44M	79.42M	88.37M	68.09M	44.59M
Net Income	6.74M	7.39M	29.14M	40.77M	29.84M	15.68M
Balance Sheet
Total Assets	715.15M	695.74M	666.27M	631.88M	615.97M	592.29M
Cash, Cash Equivalents and Short-Term Investments	32.49M	39.78M	69.30M	83.31M	87.93M	98.92M
Total Debt	47.99M	34.30M	11.10M	11.04M	12.38M	3.99M
Total Liabilities	108.97M	95.73M	72.17M	56.09M	69.88M	65.32M
Stockholders Equity	606.18M	600.00M	594.09M	575.79M	546.09M	526.97M
Cash Flow
Free Cash Flow	-2.68M	-21.25M	403.00K	12.90M	-2.73M	22.55M
Operating Cash Flow	5.09M	27.02M	56.83M	43.87M	44.12M	27.30M
Investing Cash Flow	-4.83M	-43.50M	-46.33M	-21.94M	-39.35M	4.86M
Financing Cash Flow	-9.27M	-12.42M	-34.02M	-17.05M	-15.75M	-3.19M

Lotus Eye Hospital And Institute Ltd Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 118.10
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:LOTUSEYE, the sentiment is Positive. The current price of 118.1 is above the 20-day moving average (MA) of 105.43, above the 50-day MA of 113.40, and above the 200-day MA of 106.98, indicating a neutral trend. The MACD of -1.26 indicates Negative momentum. The RSI at 51.87 is Neutral, neither overbought nor oversold. The STOCH value of 84.21 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IN:LOTUSEYE.

Lotus Eye Hospital And Institute Ltd Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
VIJAYA	75 Outperform	₹100.73B	63.11	―	0.20%	16.71%	13.92%
HCG	67 Neutral	₹81.39B	-247.47	―	―	17.58%	-38.20%
LOTUSEYE	64 Neutral	₹2.25B	-237.80	―	―	3.28%	-52.11%
KRSNAA	58 Neutral	₹19.37B	38.37	―	0.38%	11.51%	21.56%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
SHALBY	50 Neutral	₹16.58B	310.39	―	0.59%	11.49%	-91.65%

Lotus Eye Hospital And Institute Ltd Corporate Events